This company listing is no longer active
Asarina Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Asarina Pharma has a total shareholder equity of SEK1.6M and total debt of SEK1,000.0K, which brings its debt-to-equity ratio to 60.6%. Its total assets and total liabilities are SEK6.1M and SEK4.4M respectively.
Key information
60.6%
Debt to equity ratio
SEK 1.00m
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 3.16m |
| Equity | SEK 1.65m |
| Total liabilities | SEK 4.43m |
| Total assets | SEK 6.08m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ASAP's short term assets (SEK5.3M) exceed its short term liabilities (SEK4.4M).
Long Term Liabilities: ASAP's short term assets (SEK5.3M) exceed its long term liabilities (SEK2.0K).
Debt to Equity History and Analysis
Debt Level: ASAP has more cash than its total debt.
Reducing Debt: ASAP's debt to equity ratio has increased from 0% to 60.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ASAP has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ASAP has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.